CD36 knockdown alleviates lipid accumulation induced by tumor necrosis factor-α and interleukin-6 in HepG2 cells

您当前的位置：

首页 >

文章列表页 >

CD36 knockdown alleviates lipid accumulation induced by tumor necrosis factor-α and interleukin-6 in HepG2 cells

Basic Medicine | 更新时间：2026-01-09

- CD36 knockdown alleviates lipid accumulation induced by tumor necrosis factor-α and interleukin-6 in HepG2 cells
- Journal of Third Military Medical University Vol. 40, Issue 20, Pages: 1833-1838(2018)
- 作者机构：
  
  400016 重庆，重庆医科大学脂糖代谢性疾病重庆市重点实验室，脂质研究中心
- 作者简介：
- 基金信息：
  
  the National Natural Science Foundation for Young Scholars of China(81400786)
- DOI：10.16016/j.1000-5404.201805010
  CLC： R322.47;R392.3;R589.2
- Received：02 May 2018，
  
  Revised：2015-06-02，
  
  Published：30 October 2018
- 稿件说明：
移动端阅览
Li WEI, Jun WU, Lei ZHAO, et al. CD36 knockdown alleviates lipid accumulation induced by tumor necrosis factor-α and interleukin-6 in HepG2 cells[J]. Journal of Third Military Medical University, 2018, 40(20): 1833-1838.
DOI：

Li WEI, Jun WU, Lei ZHAO, et al. CD36 knockdown alleviates lipid accumulation induced by tumor necrosis factor-α and interleukin-6 in HepG2 cells[J]. Journal of Third Military Medical University, 2018, 40(20): 1833-1838. DOI： 10.16016/j.1000-5404.201805010.

摘要

目的

2

探讨炎症因子是否通过上调脂肪酸转运导致HepG2细胞脂质积聚及脂毒性。

方法

2

分别给予HepG2细胞肿瘤坏死因子(tumor necrosis factor-α

TNF-α组: 0.04 mmol/L软脂酸+25 ng/mL TNF-α)和白介素-6(interleukin-6，IL-6组: 0.04 mmol/L软脂酸+20 ng/mL IL-6)刺激处理24 h，酶法检测HepG2细胞内的甘油三酯(triglycercide，TG)水平，ELISA检测细胞内游离脂肪酸(free fatty acid，FFA)含量。利用荧光标记的软脂酸，动态监测细胞对外源性脂肪酸的摄取速率。然后利用小RNA干扰技术，构建低表达脂肪酸转运酶(cluster of differentiation

CD36)的HepG2细胞(CD36 KD HepG2)和对照细胞(NC HepG2)模型，检测CD36低表达时细胞对脂肪酸的摄取速率变化，并检测细胞内活性氧(reactive oxygen species

ROS)及过氧化氢(hydrogen peroxide

H

2

O

2

)的含量。

结果

2

炎症因子能够刺激HepG2细胞TG及FFA的累积，其中TNF-α处理组及IL-6处理组的FFA含量及TG含量都明显增加(

P

<

0.05)，并且能够引起HepG2细胞对脂肪酸的摄取增加(

P

<

0.05)。抑制HepG2细胞中CD36表达，可以减轻胞内脂质积聚(

P

<

0.05)，削弱炎症状态下HepG2细胞对脂肪酸的摄取(

P

<

0.05)，并且能够显著降低细胞内ROS及H

2

O

2

含量(

P

<

0.05)。

结论

2

在肝脏细胞中，抑制CD36的表达能够减少炎症因子TNF-α和IL-6引起的脂肪酸摄取增加，减轻脂质积聚，改善细胞脂毒性；提示CD36可作为脂肪肝等代谢性疾病的潜在治疗靶点。

Abstract

Objective

2

To investigate whether inflammatory cytokines participate in lipid accumulation and lipid toxicity by up-regulating fatty acid transport in HepG2 cells.

Methods

2

HepG2 cells were treated with 25 ng/mL tumor necrosis factor-α (TNF-α) or 20 ng/mL interleukin-6 (IL-6) in the presence of 0.04 mmol/L palmitate for 24 h

followed by enzymatic detection of triglycerides (TG) levels and ELISA to detect intracellular free fatty acid contents. The uptake rate of exogenous fatty acids was monitored using fluorescence-labeled palmitic acid. Small RNA interference technique was used to inhibit the expression of CD36 in HepG2 cells

and the changes in the uptake rate of fatty acids

intracellular reactive oxygen species (ROS)

and hydrogen peroxide (H

2

O

2

) were detected in the cells in response to TNF-α or IL-6 stimulation.

Results

2

The inflammatory cytokines TNF-α and IL-6 stimulated the accumulation of TG and FFA and aggravated intracellular lipid accumulation in HepG2 cells. Treatments of the cells with TNF-α and IL-6 both significantly increased the intracellular FFA and TG contents (

P

<

0.05) and the uptake rate of fatty acids (

P

<

0.05). CD36 knockdown significantly reduced intracellular lipid accumulation (

P

<

0.05)

intake rate of fatty acids (

P

<

0.05)

and intracellular ROS and H

2

O

2

levels in HepG2 cells with TNF-α or IL-6 stimulation (

P

<

0.05).

Conclusions

2

CD36 knockdown can reduce the uptake of fatty acids and lipid accumulation and alleviate lipotoxicity induced by inflammatory cytokines in HepG2 cells

suggesting the potential of CD36 as a therapeutic target for metabolic diseases such as fatty liver.

关键词

Keywords

references

KHOONSARI M, MOHAMMAD HOSSEINI AZAR M, GHAVAM R, et al. Clinical manifestations and diagnosis of nonalcoholic fatty liver disease[J]. Iran J Pathol, 2017, 12(2): 99-105.

DAY C P. Pathogenesis of steatohepatitis[J]. Best Pract Res Clin Gastroenterol, 2002, 16(5): 663-678. DOI: 10.1053/bega.2002.0333.

SAXTON R A, SABATINI D M. mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, 169(2): 361-371. DOI: 10.1016/j.cell.2017.03.035.

PEPINO M Y, KUDA O, SAMOVSKI D, et al. Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism[J]. Annu Rev Nutr, 2014, 34: 281-303. DOI: 10.1146/annurev-nutr-071812-161220.

LIU W, YIN Y, ZHOU Z, et al. OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation[J]. Inflamm Res, 2014, 63(1): 33-43. DOI: 10.1007/s00011-013-0667-3.

GOTODA T, IIZUKA Y, YAMADA N. Complex connection between CD36 and atherosclerosis, lipid metabolism, and insulin resistance syndromes[J]. Curr Atheroscler Rep, 2000, 2(6): 453-454. DOI: 10.1007/s11883-000-0042-z.

STEWART C R, STUART L M, WILKINSON K, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer[J]. Nat Immunol, 2010, 11(2): 155-161. DOI: 10.1038/ni.1836.

GHARIB M, TAO H, FUNGWE T V, et al. Cluster differentiating 36 (CD36) deficiency attenuates obesity-associated oxidative stress in the heart[J]. PLoS ONE, 2016, 11(5): e0155611. DOI: 10.1371/journal.pone.0155611.

MA K L, RUAN X Z, POWIS S H, et al. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice[J]. Hepatology, 2008, 48(3): 770-781. DOI: 10.1002/hep.22423.

WANG C, HU L, ZHAO L, et al. Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway[J]. PLoS ONE, 2014, 9(7): e103071. DOI: 10.1371/journal.pone.0103071.

YANG P, XIAO Y, LUO X, et al. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice[J]. J Lipid Res, 2017, 58(7): 1417-1427. DOI: 10.1194/jlr.M076216.

ZHONG S, ZHAO L, LI Q, et al. Inflammatory stress exacerbated mesangial foam cell formation and renal injury via disrupting cellular cholesterol homeostasis[J]. Inflammation, 2015, 38(3): 959-971. DOI: 10.1007/s10753-014-0058-0.

ZHAO L, ZHONG S, QU H, et al. Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice[J]. Sci Rep, 2015, 5: 10222. DOI: 10.1038/srep10222.

BIEGHS V, VAN GORP P J, WALENBERGH S M, et al. Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice[J]. Hepatology, 2012, 56(3): 894-903. DOI: 10.1002/hep.25660.

ZHOU F, PAN Y, HUANG Z, et al. Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36[J]. Cell Stress Chaperones, 2013, 18(5): 643-652. DOI: 10.1007/s12192-013-0417-z.

KOONEN D P, JACOBS R L, FEBBRAIO M, et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity[J]. Diabetes, 2007, 56(12): 2863-2871. DOI: 10.2337/db07-0907.

INOUE M, OHTAKE T, MOTOMURA W, et al. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice[J]. Biochem Biophys Res Commun, 2005, 336(1): 215-222. DOI: 10.1016/j.bbrc.2005.08.070.

GARCÍA-MONZÓN C, LO IACONO O, CRESPO J, et al. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease[J]. Eur J Clin Invest, 2014, 44(1): 65-73. DOI: 10.1111/eci.12192.

HUA W, HUANG H Z, TAN L T, et al. CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress[J]. PLoS ONE, 2015, 10(5): e0127507. DOI: 10.1371/journal.pone.0127507.

SMITH B K, JAIN S S, RIMBAUD S, et al. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation[J]. Biochem J, 2011, 437(1): 125-134. DOI: 10.1042/BJ20101861.

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Related Articles

Palmitate exacerbates intracellular lipid accumulation via up-regulating CD36 in HepG2 cells

Nicotine regulates PCSK9 expression in HepG2 cells through Raf/MEK/ERK signaling pathway

Equol intervention ameliorates steatosis in HepG2 cells induced by sodium oleate

Down-regulation of miR-4443/TIMP2 signaling pathway enhances sorafenib sensitivity in HepG2 cells

GLP-1(7-36) inhibits atherosclerosis progression in ApoE-/- mouse aorta by lowering expressions of CD36 and ACAT1 in foam cells

Related Author

谢云霞

赵蕾

张艳艳

陈压西

阮雄中

周琳

向睿

毛敏

Related Institution

Department for Nutrition and Food Safety, Chongqing Center of Medical Nutrition, Chongqing Key Laboratory of Nutrition and Food Safety, College of Military Preventive Medicine, Third Military Medical University

Department of Endocrinology, Xinqiao Hospital, Third Military Medical University

State Key Laboratory of Trauma, Burns and Combined Injury, Department 1, Institute of Surgery Research, Daping Hospital, Third Military Medical University

Laboratory Center, Xinqiao Hospital, Third Military Medical University

Department of Integrated Chinese and Western Medicine, Xinqiao Hospital, Third Military Medical University

⁰